Universal Time: 13:24  |  Local Time: 13:24 (3h GMT)
Select your timezone:

Living donation

Wednesday September 25, 2024 - 08:00 to 09:15

Room: Beylerbeyi 2

403.4 Emergent living donor liver transplantation from Korean National Data

Jongman Kim, Korea

Professor
Department of Surgery
Samsung Medical Center

Abstract

Emergent living donor liver transplantation from Korean National Data

Sang Jin Kim1, Boram Park2, Jongman Kim3, Kyunga Kim2, Geun Hong4, Young Rok Choi5, Young Seok Han6, Jun Yong Park7, Nam-Joon Yi5, Seung Heui Hong8, Youngwon Hwang9, Dong-Hwan Jung10.

1Department of Surgery, Korea University College of Medicine, Seoul, Korea; 2Biomedical Statistics Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea; 3Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; 4Department of Surgery, EWHA Womans University College of Medicine, Seoul, Korea; 5Department of Surgery, Seoul National University College of Medicine, Seoul, Korea; 6Department of Surgery, Catholic University of Daegu College of Medicine, Daegu, Korea; 7Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; 8Organ Transplant Center, Samsung Medical Center, Seoul, Korea; 9Division of Organ Transplant Management, Ministry of Health and Welfare, Seoul, Korea; 10Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Background & Aims: Emergency living donor liver transplantation (LDLT) is vital for acute liver failure or acute-on-chronic liver failure patients facing life-threatening scenarios. Our study aimed to assess risk factors influencing the urgency of patients awaiting emergency LDLT and outcomes of emergency LDLT using Korean nationwide data.
Methods: We included patients approved for emergency LDLT between 2017 and 2021. Subgroups included: 1) LDLT recipients (e-LDLT), 2) deceased-donor liver transplant recipients (DDLT; received while waiting), 3) patients who died before receiving LT (death on waiting, DOW), and 4) cases of non-emergency LDLT/ delayed LT >[A4] 14 d after application (UNN). We compared e-LDLT characteristics and survival to non-emergency LDLT controls. Adult DOW and UNN groups were compared to establish risk factors and a scoring system. Baseline characteristics, including changes in the model for end-stage liver disease (ΔMELD) scores, were analyzed.
Results: Adult e-LDLT 3-year survival rates were 78.3% (overall) and 90.1% (graft); Samsung Medical Center LDLT rates were 89.1% (overall) and 93.5% (graft). Chronic kidney disease (CKD), ventilator use, ΔMELD scores, and re-transplantation were associated with worsened adult e-LDLT survival. The leading reasons for emergency LDLT were hepatic encephalopathy, high MELD (>35), and uncontrolled bleeding. When comparing the DOW and UNN groups, hepatitis B virus (HBV), albumin, care in the intensive care unit, ventilator care, and MELD scores influenced patient mortality. A risk scoring system incorporating MELD scores (>30), serum albumin levels (≤2.8 g/dl), ΔMELD scores (>10%), and HBV status was created.
Conclusions: Emergency LDLT showed reasonable survival with CKD, ventilator use, re-LT, and ΔMELD scores as risk factors. High baseline MELD scores, ΔMELD scores, ventilator use, low albumin levels, and HBV relate to pre-LT mortality, reflecting the urgency of LT.

Present study was funded or supported by the Korean Network for Organ Sharing of the Ministry of Health and Welfare (NHIS-2022110058F-00).

References:

[1] Acute liver failure
[2] Acute-on-chronic liver failure
[3] Living liver donors
[4] Outcome

Presentations by Jongman Kim

The WebApp is sponsored by